US Losing Its Digital Edge And Cybersecurity Are Shuren’s Chief Concerns
Executive Summary
If the US Congress fails to give the Food and Drug Administration the authority it needs to regulate advancing technologies, the country could forfeit its leadership in the digital space to other countries eager to take its place.
You may also be interested in...
News We’re Watching: New CDC Director, Endologix Study Success, Hospital Closure Linked To Ransomware
This week, North Carolina health secretary Mandy Cohen was named the new head of the CDC; Congress debated PAHPA reauthorization; Cala Health launched a Parkinson’s Disease wearable; and IHealth.io was fined for consumer privacy violations.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.